aspirin has been researched along with 8-isoprostaglandin e2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alberts, P; Armesto, AR; Cattaneo, M; Daray, FM; Errasti, AE; Femia, EA; Meyer, JP; Nowak, W; Podda, GM; Pugliano, M; Razzari, C; Rothlin, RP; Sakariassen, KS; Sorensen, AS | 1 |
Celejewska-Wójcik, N; Gielicz, A; Januszek, R; Kaszuba, M; Mastalerz, L; Oleś, K; Plutecka, H; Sanak, M; Stręk, P; Wójcik, K | 1 |
2 other study(ies) available for aspirin and 8-isoprostaglandin e2
Article | Year |
---|---|
EV-077 in vitro inhibits platelet aggregation in type-2 diabetics on aspirin.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arachidonic Acid; Aspirin; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dinoprostone; Female; Hirudins; Humans; Isoprostanes; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Umbilical Arteries; Vascular Resistance | 2012 |
Aspirin provocation increases 8-iso-PGE2 in exhaled breath condensate of aspirin-hypersensitive asthmatics.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Asthma, Aspirin-Induced; Biomarkers; Breath Tests; Bronchial Provocation Tests; Bronchoconstriction; Cyclooxygenase Inhibitors; Dinoprostone; Female; Forced Expiratory Volume; Humans; Isoprostanes; Leukotriene E4; Lung; Lysine; Male; Middle Aged; Respiratory Mucosa; Severity of Illness Index; Single-Blind Method | 2015 |